Literature DB >> 22565346

Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.

Keita Miyata1, Yoshimasa Sagane, Ken Inui, Shin-Ichiro Miyashita, Tomonori Suzuki, Keiji Oguma, Tohru Ohyama, Koichi Niwa, Toshihiro Watanabe.   

Abstract

The large-sized botulinum toxin complex (L-TC) is composed of botulinum neurotoxin (BoNT) and nontoxic proteins, e.g. nontoxic nonhemagglutinin (NTNHA) and three types of hemagglutinins (HAs; HA-33, HA-17 and HA-70). The nontoxic proteins play a critical role in L-TC oral toxicity by protecting the BoNT in the digestive tract, and facilitating absorption of the L-TC across the intestinal wall. Under alkaline conditions, the L-TC separates into BoNT and the nontoxic protein complex (NC). In this study, we established a two-step procedure to yield highly pure NC from the L-TC produced by Clostridium botulinum serotype D strain 4947 in which the NC was isolated from the L-TC by gel filtration under alkaline conditions followed by immunoprecipitation with an anti-BoNT antibody to remove contaminating BoNT from the NC fraction. Western blotting and electrophoretic analysis showed that the highly purified NC fraction had only very slight or no BoNT contamination. In addition, the purified NC fraction showed no intraperitoneal (ip) toxicity to mice at a dose of 38 ng per animal whereas the L-TC exhibited an ip median lethal dose of 0.38 ng per mouse. The highly purified NC displayed the same hemagglutination titer as the L-TC. The NC, as well as the L-TC, demonstrated cell binding and monolayer transport in the rat intestinal epithelial cell line IEC-6. Consequently, the highly purified NC can function as a "delivery vehicle" even without the BoNT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565346     DOI: 10.1007/s10930-012-9413-x

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  17 in total

1.  In vitro reconstitution of the Clostridium botulinum type D progenitor toxin.

Authors:  Hirokazu Kouguchi; Toshihiro Watanabe; Yoshimasa Sagane; Hiroyuki Sunagawa; Tohru Ohyama
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

2.  Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.

Authors:  Kimiko Hasegawa; Toshihiro Watanabe; Hiroaki Sato; Yoshimasa Sagane; Shingo Mutoh; Tomonori Suzuki; Akihito Yamano; Hirokazu Kouguchi; Kouichi Takeshi; Arihide Kamaguchi; Yukako Fujinaga; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

3.  Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.

Authors:  Tohru Yoneyama; Keita Miyata; Tomoyuki Chikai; Akifumi Mikami; Tomonori Suzuki; Kimiko Hasegawa; Toshihiko Ikeda; Toshihiro Watanabe; Tohru Ohyama; Koichi Niwa
Journal:  FEMS Immunol Med Microbiol       Date:  2008-09-17

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium.

Authors:  Koichi Niwa; Kumiko Koyama; Shin-Ichi Inoue; Tomonori Suzuki; Kimiko Hasegawa; Toshihiro Watanabe; Toshihiko Ikeda; Tohru Ohyama
Journal:  FEMS Immunol Med Microbiol       Date:  2007-04

6.  Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

7.  Oral toxicities of Clostridium botulinum type A and B toxins from different strains.

Authors:  I Ohishi
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.

Authors:  T Ohyama; T Watanabe; Y Fujinaga; K Inoue; H Sunagawa; N Fujii; K Inoue; K Oguma
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

9.  Expression and stability of the nontoxic component of the botulinum toxin complex.

Authors:  Keita Miyata; Tohru Yoneyama; Tomonori Suzuki; Hirokazu Kouguchi; Ken Inui; Koichi Niwa; Toshihiro Watanabe; Tohru Ohyama
Journal:  Biochem Biophys Res Commun       Date:  2009-04-24       Impact factor: 3.575

Review 10.  Tetanus and botulism neurotoxins: a new group of zinc proteases.

Authors:  C Montecucco; G Schiavo
Journal:  Trends Biochem Sci       Date:  1993-09       Impact factor: 13.807

View more
  1 in total

1.  Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.

Authors:  Tomonori Suzuki; Thomas Nagano; Koichi Niwa; Masataka Uchino; Motohiro Tomizawa; Yoshimasa Sagane; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2016-10-26       Impact factor: 2.188

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.